Dr. Sally Temple, scientific director of the Neural Stem Cell Institute, is a trailblazer in neural stem cell research. She discusses her groundbreaking discovery of a novel stem cell in the eye that holds promise for treating macular degeneration, the leading cause of blindness. The conversation also delves into the emotional impact of losing vision versus hearing and highlights the challenges gender disparity poses within the scientific community. Finally, they touch on innovative techniques in RPE cell research and preparations for future clinical trials.